Pharmaceutical

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Invests More Than $7 Million in C2N Diagnostics’ Blood Tests

New investment supports DxA's mission to advance the development of scalable and universally accessible diagnostics.Blood tests will be key to…

1 year ago

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

Reflects Growing Commitment to Renewable Energy Sources Energize virtual power purchase agreement will provide the equivalent of 25GWh of renewable energy…

1 year ago

Bloomage’s Pioneering Pilot-Scale Testing Platform Now Fully Operational, Ushering in New Era of Open Innovation

PARSIPPANY, N.J., Sept. 25, 2024 /PRNewswire/ -- Bloomage, a global leader specializing in hyaluronic acid and other bioactive substance innovations, has…

1 year ago

RxPreferred Revolutionizes Healthcare Affordability with Launch of AI-Based Savings Program, Rx-Performance

NASHVILLE, Tenn., Sept. 25, 2024 /PRNewswire/ -- RxPreferred, a leading pharmacy benefits administrator and advocate for transparent, cost-effective healthcare solutions,…

1 year ago

Anju Showcases Innovation at 2024 SCDM Conference

CHICAGO, Sept. 25, 2024 /PRNewswire/ -- Anju, a leading provider of tailored solutions for the life sciences industry, is excited to…

1 year ago

SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices

NASHVILLE, Tenn. and RANCHO CORDOVA, Calif., Sept. 25, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in…

1 year ago

Vanderbilt University School of Medicine Basic Sciences Adds Carterra’s LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care

The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra's…

1 year ago

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology

The paper re-iterates the significant anti-fibrotic effect of Aramchol 300mg BID in patients with metabolic dysfunction associated steatohepatitis (MASH)Data is confirmed…

1 year ago

Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference

WOBURN, MA / ACCESSWIRE / September 25, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of…

1 year ago

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

CHICAGO, IL / ACCESSWIRE / September 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago